Response to letter regarding article, “Apolipoproteins, lipoprotein(a), and conventional markers of dyslipidemia in children with nephrotic syndrome in disease remission”
Author:
- 16 June 2026
- journal article
- Published by Elsevier in Journal of Clinical Lipidology
- Vol. 20 (8) , 1721-1722
Abstract
No abstract availableThis publication has 7 references indexed in Scilit:
- Apolipoproteins, lipoprotein(a), and conventional markers of dyslipidemia in children with nephrotic syndrome in disease remissionJournal of Clinical Lipidology, 2026
- Longitudinal analysis of blood pressure and lipids in childhood nephrotic syndromePediatric Nephrology, 2024
- The association of the apolipoprotein B/A1 ratio and the metabolic syndrome in children and adolescents: a systematic review and meta-analysisJournal of Diabetes & Metabolic Disorders, 2023
- Long-term risk of a major cardiovascular event by apoB, apoA-1, and the apoB/apoA-1 ratio—Experience from the Swedish AMORIS cohort: A cohort studyPLOS Medicine, 2021
- Dyslipidemia and cardiovascular health in childhood nephrotic syndromePediatric Nephrology, 2019
- Dyslipidaemia in nephrotic syndrome: mechanisms and treatmentNature Reviews Nephrology, 2017
- National Cholesterol Education Program (NCEP): Highlights of the Report of the Expert Panel on Blood Cholesterol Levels in Children and AdolescentsPediatrics, 1992